Managing Stinging Insect Allergy in the 21st Century
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Petree Hall C
1.25 CME/CE
Dennis K. Ledford , MD FAAAAI

Learning Objectives:
  1. Describe the mechanism of tolerance development during venom immunotherapy
  2. Assess the indications for initiation and discontinuation of venom immunotherapy
  3. Evaluate the overlap between venom-induced anaphylaxis and mast cell disorders
This Session Will Use Audience Response System Technology.
10:45 AM
Mechanism of Tolerance to Venom Induced By Immunotherapy
Cezmi A. Akdis, MD FAAAAI
11:05 AM
Question & Answer
11:10 AM
Initiation and Discontinuation of Venom Immunotherapy: How Long is Enough?
David B.K. Golden, MD FAAAAI
  • 2306 Golden.pdf (209.7 kB)
  • 11:30 AM
    Question & Answer
    11:35 AM
    Anaphylaxis after Hymenoptera Sting-Overlap with Mast Cell Disorder
    Mariana C. Castells, MD PhD FAAAAI
    11:55 AM
    Question & Answer
    See more of: Session